Skip to main content
. 2016 Jun 15;17(6):946. doi: 10.3390/ijms17060946

Figure 2.

Figure 2

(a) Heterocyclic hKAT-2 inhibitors; (b) structure of Compound (2), being the most potent one. The main pharmacophore of the agents is in bold.